Regarding BLC's actual profits, how are they calculated,...

Regarding BLC's actual profits, how are they calculated, specifically with regards to the jobkeeper payment? Could someone point to detailed information on BLC's revenues? I don't think I've seen what I want to see in this thread.

I'm with you on why I originally invested in CDY. It was for midkine. Later, I thought that the diversification into beauty and health would be a good idea, given that Advangen itself still seems to be a good deal. There were quite a few mistakes made and opportunities missed but that doesn't mean it can't turn out well.

If midkine was too much of an undertaking for Cellmid, maybe the health and beauty diversification saved it and will ultimately result in a profitable business. I just want to understand this BLC deal better to make up my mind about their valuation in the deal. At current prices, CDY seems undervalued regardless. Ultimately, investors will buy shares in companies that show significant revenue.